As of October 20, 2026, Kenya has confirmed nine cases of Bundibugyo virus disease. One person has died. 135 contacts are under quarantine. Because the Bundibugyo strain has no approved vaccine and no licensed therapeutic, the entire response relies on one thing: the health system’s ability to isolate, treat, and contain the virus without infecting the very healthcare workers trying to save lives. We have moved past the question of whether Kenya can detect an imported case at the airport. The question now is: Can Kenya safely and scalably treat the cases it already has? I recently conducted a comprehensive assessment of Kenya’s clinical care pillar against WHO and CDC benchmarks. I looked at six components: treatment facilities, clinical workforce, WASH infrastructure, medical supplies, referral pathways, and the continuity of essential health services. The conclusion is unavoidable: Kenya cannot deliver safe and scalable care for BVD at this moment. Here is the evidenc...
An assessment of Kenya's community protection capacity for Bundibugyo virus disease The Case That Tested the System On 5 October 2026, a Kenyan citizen who had lived in the Democratic Republic of Congo for seven years died of Bundibugyo virus disease at a Nairobi hospital. He had passed through Jomo Kenyatta International Airport two days earlier without being detected at screening. He travelled to a hospital by private means and received visitors in the ward for two to three days before the diagnosis was confirmed. Those visitors returned to their communities. The first Ebola burial in Kenya's history was conducted on 6 October at the Islamic section of Lang'ata Cemetery, within approximately twenty-four hours of death, by a nine-member team operating under strict infection prevention protocols. On 14 October, a second case was confirmed — a family member of the first patient who had been under daily monitoring since the initial diagnosis. Kenya had been on heightene...